MXPA00007394A - Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. - Google Patents
Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.Info
- Publication number
- MXPA00007394A MXPA00007394A MXPA00007394A MXPA00007394A MXPA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- treating
- compounds
- methods
- associated diseases
- Prior art date
Links
- 208000004692 Pneumovirus Infections Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7303898P | 1998-01-29 | 1998-01-29 | |
| US7307898P | 1998-01-30 | 1998-01-30 | |
| PCT/US1999/001985 WO1999038508A1 (en) | 1998-01-29 | 1999-01-29 | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA00007394A true MXPA00007394A (es) | 2003-08-01 |
Family
ID=26754055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA00007394A MXPA00007394A (es) | 1998-01-29 | 1999-01-29 | Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1051169A4 (es) |
| JP (1) | JP2002501894A (es) |
| CN (1) | CN1289248A (es) |
| AU (1) | AU759772B2 (es) |
| BR (1) | BR9908522A (es) |
| CA (1) | CA2319465C (es) |
| MX (1) | MXPA00007394A (es) |
| NZ (1) | NZ505894A (es) |
| WO (1) | WO1999038508A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489338B2 (en) | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
| CN100560131C (zh) | 2001-10-22 | 2009-11-18 | 斯克里普斯研究学院 | 抗体靶向化合物 |
| CA2495266A1 (en) * | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| AU2003258177A1 (en) | 2002-08-09 | 2004-02-25 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EP1682547B1 (en) | 2003-10-30 | 2012-10-24 | Boehringer Ingelheim (Canada) Ltd. | Rsv polymerase inhibitors |
| US8247576B2 (en) | 2003-12-23 | 2012-08-21 | Astex Therapeutics Limited | Pyrazole derivatives as protein kinase modulators |
| WO2006136821A1 (en) | 2005-06-22 | 2006-12-28 | Astex Therapeutics Limited | Pharmaceutical compounds |
| JP5345842B2 (ja) | 2005-06-23 | 2013-11-20 | アステックス・セラピューティクス・リミテッド | プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ |
| GB0704932D0 (en) | 2007-03-14 | 2007-04-25 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| JP2012517447A (ja) | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | 化学的にプログラムされたワクチン接種法 |
| EP2867216A4 (en) * | 2012-06-29 | 2015-12-09 | Microdose Therapeutx Inc | COMPOSITIONS AND METHODS OF TREATING PNEUMOVIRAL INFECTIONS AND ASSOCIATED DISEASES |
| EP3081569B1 (en) | 2013-12-10 | 2019-09-18 | Shandong Danhong Pharmaceutical Co., Ltd. | Imidazole derivative used as antiviral agent and use thereof in preparation of medicament |
| JP6548751B2 (ja) | 2015-06-08 | 2019-07-24 | シャンドン ダンホン ファーマスーティカル カンパニー リミテッドShandong Danhong Pharmaceutical Co., Ltd. | イミダゾール誘導体及びその中間体の製造及び結晶型 |
| WO2020252396A1 (en) * | 2019-06-13 | 2020-12-17 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of respiratory syncytial virus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1508391A (en) * | 1975-01-20 | 1978-04-26 | Sterling Drug Inc | Phenylalkylamines |
| US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
| US5098920A (en) * | 1990-05-04 | 1992-03-24 | G. D. Searle & Co. | 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders |
| EP0714292A4 (en) * | 1993-06-23 | 1996-10-09 | Cambridge Neuroscience Inc | SIGMA RECEPTOR LIGANDS AND THEIR USE |
| AU6475696A (en) * | 1995-07-27 | 1997-02-26 | Warner-Lambert Company | Substituted phenols as novel calcium channel blockers |
| CN1163401A (zh) * | 1996-02-13 | 1997-10-29 | 李占元 | 全自动血球计数仪试剂及配制方法 |
| CA2250464A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors |
-
1999
- 1999-01-29 NZ NZ505894A patent/NZ505894A/xx unknown
- 1999-01-29 WO PCT/US1999/001985 patent/WO1999038508A1/en not_active Ceased
- 1999-01-29 EP EP99905546A patent/EP1051169A4/en not_active Withdrawn
- 1999-01-29 BR BR9908522-4A patent/BR9908522A/pt not_active Application Discontinuation
- 1999-01-29 CA CA2319465A patent/CA2319465C/en not_active Expired - Lifetime
- 1999-01-29 MX MXPA00007394A patent/MXPA00007394A/es unknown
- 1999-01-29 CN CN99802500A patent/CN1289248A/zh active Pending
- 1999-01-29 JP JP2000529241A patent/JP2002501894A/ja active Pending
- 1999-01-29 AU AU25685/99A patent/AU759772B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN1289248A (zh) | 2001-03-28 |
| CA2319465A1 (en) | 1999-08-05 |
| JP2002501894A (ja) | 2002-01-22 |
| NZ505894A (en) | 2002-12-20 |
| BR9908522A (pt) | 2001-10-02 |
| AU759772B2 (en) | 2003-05-01 |
| EP1051169A1 (en) | 2000-11-15 |
| EP1051169A4 (en) | 2002-05-29 |
| CA2319465C (en) | 2013-03-19 |
| WO1999038508A1 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1128832A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES | |
| EP1109580A4 (en) | METHOD FOR TREATING OR PREVENTING VIRAL INFECTIONS AND RELATED DISEASES | |
| EP1115286A4 (en) | METHOD FOR TREATING AND PREVENTING VIRAL INFECTIONS AND DISEASES RELATED TO THEM | |
| MX264033B (es) | Tratamieno de enzimas para infeccion. | |
| ZA200004956B (en) | Vaccine composition. | |
| MX221888B (es) | Composicion plaguicida para tratamiento de semillas. | |
| WO2001017543A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
| ZA200108912B (en) | Attenuated microorganisms for the treatment of infection. | |
| ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
| MXPA00007394A (es) | Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas. | |
| EP0920419A4 (en) | CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING FLU | |
| AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
| ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
| ZA200109845B (en) | Hair treatment compositions. | |
| AU2003258176A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| GB9815312D0 (en) | Biomas treatment | |
| GB9917593D0 (en) | Compound, composition, process and use | |
| PL345068A1 (en) | Novel compounds derived from α-d-xylose, preparation method and therapeutic use | |
| ZA200002546B (en) | Sorbate-preserved compositions, method for the manufacture thereof and their use. | |
| AU2003237088A8 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
| AU6798000A (en) | Compounds, compositions and methods for treating influenza | |
| ZA99253B (en) | Treatment of waxes. | |
| AU2003258177A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| HK1029938A (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| ZA200007396B (en) | Method of treatment. |